Xi Chu

2.6k total citations
98 papers, 2.0k citations indexed

About

Xi Chu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Xi Chu has authored 98 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 25 papers in Cardiology and Cardiovascular Medicine and 18 papers in Oncology. Recurrent topics in Xi Chu's work include Cardiac electrophysiology and arrhythmias (13 papers), Saffron Plant Research Studies (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Xi Chu is often cited by papers focused on Cardiac electrophysiology and arrhythmias (13 papers), Saffron Plant Research Studies (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Xi Chu collaborates with scholars based in China, Australia and United States. Xi Chu's co-authors include Li Chu, Jianping Zhang, Xuan Zhang, Bin Zheng, Xue Han, Xue Han, Yingran Liang, Yuanyuan Zhang, Jing Shi and Yucong Xue and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Xi Chu

95 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi Chu China 26 844 284 253 248 247 98 2.0k
Xue Han China 26 812 1.0× 166 0.6× 168 0.7× 191 0.8× 238 1.0× 99 2.1k
Xu Han China 27 971 1.2× 178 0.6× 254 1.0× 179 0.7× 379 1.5× 53 2.3k
Jianping Zhang China 28 852 1.0× 245 0.9× 154 0.6× 502 2.0× 301 1.2× 114 2.3k
Yangyang Hu China 20 869 1.0× 171 0.6× 306 1.2× 314 1.3× 142 0.6× 53 2.1k
Yuxia Zhao China 27 1.0k 1.2× 472 1.7× 261 1.0× 180 0.7× 216 0.9× 67 2.3k
Ebtehal El‐Demerdash Egypt 29 691 0.8× 266 0.9× 136 0.5× 263 1.1× 288 1.2× 82 2.3k
Wu Luo China 26 1.3k 1.5× 414 1.5× 463 1.8× 198 0.8× 183 0.7× 92 2.5k
Nehal M. Elsherbiny Egypt 36 1.2k 1.4× 142 0.5× 218 0.9× 226 0.9× 331 1.3× 114 3.2k
Xufeng Tao China 29 1.3k 1.5× 354 1.2× 318 1.3× 322 1.3× 267 1.1× 66 2.7k
Xiaoyan Zhao China 27 985 1.2× 164 0.6× 118 0.5× 225 0.9× 249 1.0× 99 2.3k

Countries citing papers authored by Xi Chu

Since Specialization
Citations

This map shows the geographic impact of Xi Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Chu more than expected).

Fields of papers citing papers by Xi Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Chu. The network helps show where Xi Chu may publish in the future.

Co-authorship network of co-authors of Xi Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Chu. A scholar is included among the top collaborators of Xi Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Chu. Xi Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yan, Si Jin, Yinghua Zhang, et al.. (2025). Association between Metabolic Syndrome Score and Subclinical Atherosclerosis. Reviews in Cardiovascular Medicine. 26(3). 26811–26811.
2.
Wang, Hongyang, et al.. (2025). Integrated network pharmacology, molecular docking, and animal experiments to reveal the potential mechanism of hesperetin on COPD. Scientific Reports. 15(1). 11024–11024. 1 indexed citations
3.
4.
5.
Zhang, Haoyu, Yinghua Zhang, Yang Wang, et al.. (2024). Association between exposure to air pollution and arterial stiffness in participants with and without atherosclerotic cardiovascular disease. Clinical Research in Cardiology. 1 indexed citations
6.
Chu, Xi, Jun Zhang, Yun Song, et al.. (2023). Safety and efficacy of endovascular recanalization for symptomatic non-acute atherosclerotic intracranial large artery occlusion. Frontiers in Neurology. 14. 1144622–1144622. 5 indexed citations
7.
Chen, Ning, et al.. (2023). Association of variability in metabolic parameters with the incidence of type 2 diabetes: evidence from a functional community cohort. Cardiovascular Diabetology. 22(1). 183–183. 6 indexed citations
8.
Zhang, Yinghua, Haoyu Zhang, Ting Zhao, et al.. (2023). The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk. Clinical Cardiology. 46(10). 1260–1267. 1 indexed citations
9.
Han, Xue, Panpan Liu, Bin Zheng, et al.. (2022). 6-Gingerol exerts a protective effect against hypoxic injury through the p38/Nrf2/HO-1 and p38/NF-κB pathway in H9c2 cells. The Journal of Nutritional Biochemistry. 104. 108975–108975. 14 indexed citations
10.
Dong, Jing, Yuhong Liu, Ning Chen, et al.. (2022). Association between surrogate indicators of insulin resistance and risk of type 2 diabetes combined with hypertension among Chinese adults: two independent cohort studies. Nutrition & Metabolism. 19(1). 85–85. 13 indexed citations
11.
Sun, Yue, et al.. (2022). Associations of waist-to-height ratio with the incidence of type 2 diabetes and mediation analysis: Two independent cohort studies. Obesity Research & Clinical Practice. 17(1). 9–15. 7 indexed citations
12.
Liu, Miaomiao, Bin Zheng, Panpan Liu, et al.. (2021). Exploration of the hepatoprotective effect and mechanism of magnesium isoglycyrrhizinate in mice with arsenic trioxide‑induced acute liver injury. Molecular Medicine Reports. 23(6). 17 indexed citations
13.
Zhang, Muqing, Yucong Xue, Bin Zheng, et al.. (2021). Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy. Biomedicine & Pharmacotherapy. 143. 112167–112167. 55 indexed citations
14.
Li, Mengying, Panpan Liu, Yucong Xue, et al.. (2020). Tannic acid attenuates hepatic oxidative stress, apoptosis and inflammation by activating the Keap1‑Nrf2/ARE signaling pathway in arsenic trioxide‑toxicated rats. Oncology Reports. 44(5). 2306–2316. 26 indexed citations
15.
Liu, Di, Xi Chu, Hao Wang, et al.. (2018). The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia. Journal of Translational Medicine. 16(1). 235–235. 59 indexed citations
16.
Zhang, Jianping, Qiongtao Song, Xue Han, et al.. (2017). Multi-targeted protection of acetaminophen-induced hepatotoxicity in mice by tannic acid. International Immunopharmacology. 47. 95–105. 57 indexed citations
17.
Zhou, Yihong, Liang Tong, Xi Chu, et al.. (2017). The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma. Cellular Physiology and Biochemistry. 43(2). 733–742. 36 indexed citations
18.
Zhang, Jianping, Xue Han, Yuanyuan Zhang, et al.. (2017). Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis. Biomedicine & Pharmacotherapy. 93. 1253–1260. 71 indexed citations
19.
Dong, Jianzeng, et al.. (2015). Association between the abdominal obesity anthropometric indicators and metabolic disorders in a Chinese population. Public Health. 131. 3–10. 25 indexed citations
20.
Chu, Xi, Hua Wang, Yuanyuan Zhang, et al.. (2015). Ameliorative effects of tannic acid on carbon tetrachloride-induced liver fibrosis in vivo and in vitro. Journal of Pharmacological Sciences. 130(1). 15–23. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue Han Breakdown of academic impact, for papers by Xu Han Breakdown of academic impact, for papers by Jianping Zhang Breakdown of academic impact, for papers by Yangyang Hu Breakdown of academic impact, for papers by Yuxia Zhao Breakdown of academic impact, for papers by Ebtehal El‐Demerdash Breakdown of academic impact, for papers by Wu Luo Breakdown of academic impact, for papers by Nehal M. Elsherbiny Breakdown of academic impact, for papers by Xufeng Tao Breakdown of academic impact, for papers by Xiaoyan Zhao
Rankless by CCL
2026